ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2022

IL-38, a potential therapeutic agent for lupus, inhibits lupus progression.

Wang-Dong Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.